Keratoconus Treatment Market Size, Share, Applications, Regions, Top Companies, Trends, Drivers and Forecast till 2027
The global keratoconus treatment market
has been assessed as a progressing market and is expected to grow at a CAGR of
4.1% and attain USD 427.5 Million by the end of 2023, proclaims Market Research
Future (MRFR) in a minutely analyzed research report. Advancement in
diagnostics and treatment options along with rising prevalence of keratoconus
is the primary driver of the market growth. The government in various countries
have endeavored towards raising awareness regarding the disease and provide
various aids to patients suffering from keratoconus which boosts the growth of
the market. Moreover, the market players are pouring in money for the
development of novel therapies for the disease which has been a plus for the
market growth. Moreover, the rise in a number of approvals by the FDA for
various new drugs and treatments bolsters the growth of the market.
Competitive Landscape
The notable players operating in the
global keratoconus
market include Bausch & Lomb Incorporated (US), CooperVision (US),
Johnson & Johnson Vision Care, Inc. (US), Novartis AG (Switzerland),
SAFILENS S.R.L. (Italy), CIBA VISION (US), HOYA Vision Care (Singapore),
Menicon Co., Ltd. (Japan), Optik Seis (Indonesia), and others.
Get Sample Report: https://www.marketresearchfuture.com/sample_request/3861
Segmentation
The global keratoconus treatment market
has been segmented based on type, diagnosis, treatment, and end users. By type,
the market has been segmented into forme fruste keratoconus, corneal hydrops,
keratoglobus, pellucid marginal degeneration, posterior keratoconus, and
others. By diagnosis, the market has been segmented into computerized corneal
mapping, keratometry, slit-lamp examination, refraction test, and others. The
Slit-lamp examination segment has been further segmented into tonometry, vision
testing, and others. By treatment, the market has been segmented into Lenses,
Surgery, and others. Lenses segment is further segmented into eyeglasses or
soft contact lenses, hard contact lenses, piggyback lenses, hybrid lenses,
scleral lenses, and others. Surgery segment is further segmented into corneal
inserts, cornea transplant, and others. Collagen cross-linking is still in the
research process, and more study is required to implement this treatment
option. By end users, the market has been segmented into eye hospitals &
clinics, medical research centers, academic institutes, and others.
Regional Analysis
The global keratoconus treatment market
spans across the regions of the Americas, Europe, Asia Pacific, and the Middle
East and Africa. The Americas dominate the global keratoconus treatment market,
led by the US. Advances in technology and rapid adoption of new treatments and
therapies support the growth of the market in the region. Europe follows the
Americas closely and is driven by substantial investment in R&D for the
development of new products. Germany is the key contributor to the Europe
market. Asia Pacific is poised to emerge as the fastest growing market for the
treatment of keratoconus owing to increasing awareness of the disease and high
expenditure on healthcare in the region, China being the key contributor to the
growth of the market. The Middle East & Africa market is expected to have
limited growth over the forecast period, although the Middle Eastern countries
are expected to grow significantly.
Industry Updates
In August 2018, the FDA approved the
first medication to treat keratoconus, which is a rare eye disease. An Italian
company can sell the drug named Oxervate in the US and has also been approved
by the European Medicines Agency.
Access Report Details @ https://www.marketresearchfuture.com/reports/keratoconus-treatment-market-3861
Related
Report: Dysmenorrhea
Treatment Market Research Report- Global Forecast to 2027
Syringe
and Needle Market Research Report - Global Forecast to 2027
Global
Medical Robotics Market Research Report- Forecast To 2027
Global
Neuromodulation Devices Market Research Report- Forecast To 2027
Global
Erythropoietin Drug Market Research Report- Forecast To 2027
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
Comments
Post a Comment